FI932909A0 - Foergrenade alkylaminoderivat av tiazol, foerfaranden foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa - Google Patents

Foergrenade alkylaminoderivat av tiazol, foerfaranden foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa

Info

Publication number
FI932909A0
FI932909A0 FI932909A FI932909A FI932909A0 FI 932909 A0 FI932909 A0 FI 932909A0 FI 932909 A FI932909 A FI 932909A FI 932909 A FI932909 A FI 932909A FI 932909 A0 FI932909 A0 FI 932909A0
Authority
FI
Finland
Prior art keywords
radical
cycloalkyl
alkyl
phenyl
foergrenade
Prior art date
Application number
FI932909A
Other languages
English (en)
Other versions
FI932909A (fi
Inventor
Gilles Courtemanche
Claudie Gautier
Danielle Gully
Pierre Roger
Gerard Valette
Camille Georges Wermuth
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of FI932909A0 publication Critical patent/FI932909A0/fi
Publication of FI932909A publication Critical patent/FI932909A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI932909A 1992-06-24 1993-06-23 Foergrenade alkylaminoderivat av tiazol, foerfaranden foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa FI932909A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929207736A FR2692893B1 (fr) 1992-06-24 1992-06-24 Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
FI932909A0 true FI932909A0 (fi) 1993-06-23
FI932909A FI932909A (fi) 1993-12-25

Family

ID=9431129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932909A FI932909A (fi) 1992-06-24 1993-06-23 Foergrenade alkylaminoderivat av tiazol, foerfaranden foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa

Country Status (30)

Country Link
US (1) US5464847A (fi)
EP (1) EP0576350B1 (fi)
JP (1) JPH0656809A (fi)
KR (1) KR100228813B1 (fi)
CN (1) CN1035552C (fi)
AT (1) ATE159721T1 (fi)
AU (1) AU665256B2 (fi)
BR (1) BR9302643A (fi)
CA (1) CA2099062A1 (fi)
CZ (1) CZ125293A3 (fi)
DE (1) DE69314855T2 (fi)
DK (1) DK0576350T3 (fi)
ES (1) ES2110070T3 (fi)
FI (1) FI932909A (fi)
FR (1) FR2692893B1 (fi)
GR (1) GR3025684T3 (fi)
HK (1) HK1002632A1 (fi)
HU (1) HUT66384A (fi)
IL (1) IL106088A (fi)
IS (1) IS4040A (fi)
MX (1) MX9303770A (fi)
MY (1) MY109557A (fi)
NO (1) NO303118B1 (fi)
NZ (1) NZ247949A (fi)
PH (1) PH30921A (fi)
PL (2) PL176103B1 (fi)
RU (1) RU2102389C1 (fi)
SG (1) SG50626A1 (fi)
SI (1) SI9300337A (fi)
TW (1) TW256834B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE4401912A1 (de) * 1994-01-24 1995-07-27 Basf Ag Methinfarbstoffe in der nichtlinearen Optik
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
PT863882E (pt) 1995-10-17 2002-07-31 Janssen Pharmaceutica Nv Pirimidinas e triazinas amino-substituidas
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US5861398A (en) * 1996-08-26 1999-01-19 Alanex Corporation Benzoperimidine-carboxylic acids and derivatives thereof
US6159980A (en) * 1996-09-16 2000-12-12 Dupont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
AU6279598A (en) 1997-02-18 1998-09-08 Neurocrine Biosciences, Inc. Biazacyclic CRF antagonists
PT1129096E (pt) 1998-11-12 2003-09-30 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
WO2000027846A2 (en) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
US6531475B1 (en) 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
AU2002314744A1 (en) * 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
US7276526B2 (en) 2001-07-13 2007-10-02 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
EP1285914B1 (en) * 2001-08-13 2007-12-19 PheneX Pharmaceuticals AG Nr1h4 nuclear receptor binding compounds
JP4484439B2 (ja) * 2002-03-14 2010-06-16 国立大学法人東京工業大学 Ｖｄａｃ調節剤
AU2003213351A1 (en) * 2002-03-14 2003-09-22 Takeda Chemical Industries, Ltd. Vdac regulator
DK1700856T3 (en) * 2003-12-26 2015-12-14 Kyowa Hakko Kirin Co Ltd thiazole
WO2007089679A2 (en) * 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
ATE546437T1 (de) * 2006-10-19 2012-03-15 Hoffmann La Roche Aminomethyl-4-imidazole
JP5467735B2 (ja) * 2007-07-02 2014-04-09 東ソー株式会社 円筒形スパッタリングターゲット
IL296683B2 (en) 2014-01-21 2023-12-01 Neurocrine Biosciences Inc Preparations for the treatment of congenital adrenal hyperplasia
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264134A (en) * 1978-05-26 1981-04-28 Elliott Brothers (London) Limited Display arrangements
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler
US5232921A (en) * 1987-03-12 1993-08-03 Sanofi Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.

Also Published As

Publication number Publication date
HK1002632A1 (en) 1998-09-04
HUT66384A (en) 1994-11-28
PH30921A (en) 1997-12-23
DK0576350T3 (da) 1998-07-20
IL106088A (en) 1997-09-30
NO303118B1 (no) 1998-06-02
HU9301850D0 (en) 1993-09-28
FR2692893A1 (fr) 1993-12-31
GR3025684T3 (en) 1998-03-31
EP0576350A1 (fr) 1993-12-29
SI9300337A (en) 1994-03-31
KR100228813B1 (ko) 1999-11-01
FI932909A (fi) 1993-12-25
DE69314855D1 (de) 1997-12-04
PL174734B1 (pl) 1998-09-30
RU2102389C1 (ru) 1998-01-20
TW256834B (fi) 1995-09-11
PL176103B1 (pl) 1999-04-30
IS4040A (is) 1993-12-25
CZ125293A3 (en) 1994-01-19
ATE159721T1 (de) 1997-11-15
ES2110070T3 (es) 1998-02-01
NO932319D0 (no) 1993-06-23
MX9303770A (es) 1994-05-31
AU4139993A (en) 1994-01-06
CN1085898A (zh) 1994-04-27
US5464847A (en) 1995-11-07
KR940000447A (ko) 1994-01-03
EP0576350B1 (fr) 1997-10-29
IL106088A0 (en) 1993-10-20
CA2099062A1 (en) 1993-12-25
FR2692893B1 (fr) 1994-09-02
NZ247949A (en) 1994-10-26
PL299445A1 (en) 1994-01-24
DE69314855T2 (de) 1998-05-20
JPH0656809A (ja) 1994-03-01
MY109557A (en) 1997-02-28
AU665256B2 (en) 1995-12-21
NO932319L (no) 1993-12-27
BR9302643A (pt) 1994-01-11
CN1035552C (zh) 1997-08-06
SG50626A1 (en) 1998-07-20

Similar Documents

Publication Publication Date Title
FI932909A0 (fi) Foergrenade alkylaminoderivat av tiazol, foerfaranden foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa
RU93035829A (ru) Производные аминохинолона, замещенные арильной или гетероароматической группой, и анти-вич средства
SE8804586D0 (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
DK289888A (da) 2-substitueret-e-kondenserede oe1,2,4,aatriazolooe1,5-caapyrimidiner, farmaceutiske praeparater og anvendelser deraf
DE3874845D1 (de) Substituierte triazolinone.
HUT45845A (en) Insecticides and acaricides and process for producing 1-aryl-pyrazole derivatives applicable as active ingredient
FI906108A (fi) Serotoninantagonister, deras framstaellning och dessa innehaollande laekemedel.
ZA978652B (en) Flavone compounds, process for preparing them and pharmaceutical compositions containing them.
SE8503111D0 (sv) 1,4-dihydropyridinderivat och salter derav, forfarande for deras framstellning och farmaceutisk komposition innehallande dessa
DE3879653D1 (de) Virusinhibierende heterocyclische verbindungen.
DK0579059T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
AU7042281A (en) Aminopropanol derivatives
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
HU9601325D0 (en) Process for producing in a given case in second position substituted fifth-chlorine-imidazole-4-carbaldehyde-derivates
TW337983B (en) 1, 3-oxazn-4-one derivatives, their preparation and uses

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: SANOFI